Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone taper versus abrupt stop in Bell's palsy
MOH_2020-03-07_008758Phase 4Recruiting
- Sponsor
- ד"ר יניר יואב, ד"ר כהן כרם רענן
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone in Bell's palsy (2 arms), sponsored by ד"ר יניר יואב, ד"ר כהן כרם רענן. Primary endpoints: Efficacy of prednisone without tapering and Safety of prednisone without tapering. Started Feb 2020; status: recruiting.
02
Drugs
prednisone
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on MOH_2020-03-07_008758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-03-07_008758.